|
[1]FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al.Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136 (5) :e359-e386.
|
|
[2]SHEN F, CHENG ZJ.Understanding of clinical research on liver cancer in the era of precision medicine and big data[J].Chin J Pract Surg, 2016, 36 (6) :599-602. (in Chinese) 沈锋, 程张军.精准医学和大数据时代对肝癌临床研究的认识[J].中国实用外科杂志, 2016, 36 (6) :599-602.
|
|
[3]WU WB, YI HF, HUANG WQ, et al.Study on the relationship between hepatitis B virus infection and recurrence and metastasis of hepatocellular carcinoma[J].Chin J Nosocomiol, 2016, 26 (4) :744-746. (in Chinese) 吴卫兵, 尹华发, 黄文琪, 等.肝炎病毒感染与肝细胞性肝癌患者术后复发转移的相关性研究[J].中华医院感染学杂志, 2016, 26 (4) :744-746.
|
|
[4]SUN Q, WANG R, WANG Y, et al.Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma[J].Oncol Rep, 2014, 31 (2) :933-939.
|
|
[5]LU Y, LI W, ZHU MY, et al.The effect of hepatitis B virus Xgene on the expression of ras in human hepatoma cells Bel7402[J].China Med Herald, 2015, 12 (32) :9-12. (in chinese) 鲁琰, 李伟, 朱明月, 等.乙肝病毒X基因对肝癌Bel7402细胞ras基因表达的影响[J].中国医药导报, 2015, 12 (32) :9-12.
|
|
[6]LI D, DING J, CHEN Z, et al.Accurately mapping the location of the binding site for the interaction between hepatitis B virus X protein and cytochrome c oxidase III[J].Mol Med, 2015, 35 (2) :319-324.
|
|
[7]WANG MR.Interpretation of the guidelines for prevention and treatment of chronic hepatitis B in the 2008 Asia Pacific Society for the study of liver diseases[J].Mil Med J Southeast China, 2008, 10 (4) :241-242. (in Chinese) 汪茂荣.解读《2008亚太肝病研究学会慢性乙型肝炎防治指南》[J].东南国防医药, 2008, 10 (4) :241-242.
|
|
[8]DATTA S, ROYCHOUDHURY S, GHOSH A, et al.Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients[J].PLo S One, 2014, 9 (7) :e102573.
|
|
[9]DATTA S, GHOSH A, DASGUPTA D, et al.Novel point and combo-mutations in the genome of hepatitis B virus-genotype D:characterization and impact on liver disease progression to hepatocellular carcinoma[J].PLo S One, 2014, 9 (10) :e110012.
|
|
[10]CHEN KH, GAO T, PAN JF, et al.DHA can inhibit the migration and invasion of hepatocellular carcinoma cells induced by aflatoxin B1[J].J South Med Univ, 2016, 36 (7) :952-956. (in Chinese) 陈可和, 高婷, 潘金飞, 等.DHA可抑制黄曲霉素B1诱导的肝癌细胞迁移及侵袭[J].南方医科大学学报, 2016, 36 (7) :952-956.
|
|
[11]WU HC, TSAI HW, TENG CF, et al.Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibitenhanced oncogenic effects and tumorigenesis[J].Hum Pathol, 2014, 45 (6) :1294-1301.
|
|
[12]PARK CY, CHOI SH, KANG SM, et al.Nonstructural 5A protein activates beta-catenin signaling cascades:implication of hepatitis C virus-induced liver pathogenesis[J].J Hepatol, 2009, 51 (5) :853-864.
|
|
[13]KASPRZAK A, ADAMEK A.Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis[J].Hepatol Res, 2008, 38 (1) :1-26.
|
|
[14]PANG T, XING HC.Analysis of the relationship between drug resistance gene mutation and hepatocellular carcinoma in HBV infected patients[J].J Clin Hepatol, 2017, 33 (1) :82-86. (in Chinese) 庞婷, 邢卉春.HBV感染者耐药基因突变与肝细胞癌的相关性分析[J].临床肝胆病杂志, 2017, 33 (1) :82-86.
|
|
[15]SHU Y, WANG W, DAI P, et al.Mutation analysis of hepatitis B virus genome BCP/Pre C gene mutation in patients with hepatocellular carcinoma[J].Chin J Virol, 2017, 33 (1) :36-43. (in Chinese) 束毅, 王伟, 代鹏, 等.肝癌患者体内乙型肝炎病毒基因组BCP/Pre C区基因突变多样性分析[J].病毒学报, 2017, 33 (1) :36-43.
|
|
[16]HUANG Y, LUO X, CHEN YM, et al.Study on the expression of HBV covalently closed circular DNA in liver tissue of patients with hepatocellular carcinoma and its correlation with e antigen[J].JChongqing Med Univ, 2015, 40 (11) :1430-1433. (in Chinese) 黄瑶, 罗璇, 陈彦猛, 等.肝癌患者肝组织中乙肝病毒共价闭合环状DNA表达水平及与e抗原相关性研究[J].重庆医科大学学报, 2015, 40 (11) :1430-1433.
|
|
[17]PARK YM, JANG JM, YOO SH, et al.Combinations of eight key mutations in the X/pre C region and genomic activity of hepatitis Bvirus are associated with hepatocellular carcinoma[J].J Viral Hepat, 2014, 21 (3) :171-177.
|
|
[18]SAMUELE de MINICIS, MARCO MARZIONI, ANTONIO BENE-DETTI, et al.New insights into hepatocellular carcinoma:from experiment to clinic[J].Chin J Gen Surg, 2015, 24 (1) :1-9. (in Chinese) Samuele de Minicis, Marco Marzioni, Antonio Benedetti, 等.肝细胞癌的新见解:从实验到临床[J].中国普通外科杂志, 2015, 24 (1) :1-9.
|
|
[19]PEZ F, LOPEZ A, KIM M, et al.Wnt signaling and hepatocarcinogenesis:molecular targets for the development of innovative anticancer drugs[J].J Hepatol, 2013, 59 (5) :1107-1117.
|
|
[20]LUCIFORA J, XIA Y, REISINGER F, et al.Specific and nonhepatotoxic degradation of nuclear hepatitis B virus ccc DNA[J].Science, 2014, 343 (6176) :1221-1228.
|
|
[21]MUN HS, LEE SA, KIM H, et al.Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular earcionma in patients with chronic genotype C infe-ctions[J].Virology, 2011, 85 (1) :123-132.
|
|
[22]JANG XB, LI YP, LI ZR.Research progress of HCV NS5A inhibitors[J].Acta Pharm Sin, 2016, 51 (9) :1378-1387. (in Chinese) 姜心贝, 李艳萍, 李卓荣.HCV NS5A抑制剂研究进展[J].药学学报, 2016, 51 (9) :1378-1387.
|
|
[23]LAMBERT SM, LANGLEY DR, GARNETT JA, et al.The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors[J].Protein Sci, 2014, 23 (6) :723-734.
|
|
[24]ZHANG XL.Isolation and drug resistance of liver cancer stem like cells regulated by Akt pathway[D].Chongqing Med Univ, 2013. (in Chinese) 张小丽.肝癌干细胞样细胞的分离及其耐药性受Akt通路调节[D].重庆医科大学, 2013.
|
|
[25] ARK CY, CHOI SH, KANG SM, et al.Nonstructural 5A protein activates beta-catenin signaling cascades:implication of hepatitis C virus-induced liver pathogenesis[J].J Hepatol, 2009, 51 (5) :853-864.
|
|
[26]NELSON DR, COOPER JN, LALEZARI JP, et al.All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection:ALLY-3 Phase III Study[J].Hematology, 2015, 61 (4) :1127-1135.
|
|
[27]CHAYAMA K, HAYES CN.Hepatitis C virus:how genetic variability affects pathobiology of disease[J].J Gastroenterol Hepatol, 2011, 26 (Suppl 1) :83-95.
|
|
[28]RAIMONDI S, BRUNO S, MONDELLI MU, et al.Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development:a meta-analysis[J].J Hepatol, 2009, 50 (6) :1142-1154.
|
|
[29]MEER AJ, VELDT BJ, FELD JJ, et al.Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis[J].JAMA, 2012, 308 (24) :2584-2593.
|
|
[30]ZHANG X, LIU S, HU T, et al.Up-regulated microRNA-143transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression[J].Hepatology, 2009, 50 (2) :490-499.
|
|
[31] KONG G, ZHANG J, ZHANG S, et al.Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model[J].PLo S One, 2011, 6 (5) :e19518.
|
|
[32] YUAN K, LIAN Z, SUN B, et al.Role of miR-148a in hepatitis B associated hepatocellular carcinoma[J].PLo S One, 2012, 7 (4) :e35331.
|
|
[33]PLACE RF, LI LC, POOKOT D, et al.MicroRNA-373 induces expression of genes with complementary promoter sequences[J].Proc Natl Acad Sci U S A, 2008, 105 (5) :1608-1613.
|
|
[34] WU G, YU F, XIAO Z, et al.Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro[J].Br J Cancer, 2011, 105 (1) :146-153.
|
|
[35] HUNG CH, HU TH, LU SN, et al.Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus[J].Int J Cancer, 2015, 138 (3) :714-720.
|
|
[36]SHRIVASTAVA S, STEELE R, RAY R, et al.MicroRNAs:role in hepatitis C virus pathogenesis[J].Genes Dis, 2015, 2 (1) :35-45.
|
|
[37]LI ZY, LU ZM, ZHAO XX, et al.Progress on miRNA in hepatocellular carcinoma[J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (4) :11-13. (in chinese) 李子英, 卢再鸣, 赵相轩, 等.微小RNA与原发性肝癌的研究进展[J/CD].中国肝脏病杂志:电子版, 2015, 7 (4) :11-13.
|
|
[38] ZHANG X, LIU S, HU T, et al.Up-regulated microRNA-143transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression[J].Hepatology, 2009, 50 (2) :490-499.
|
|
[39]KONG G, ZHANG J, ZHANG S, et al.Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model[J].PLo S One, 2011, 6 (5) :e19518.
|
|
[40]YUAN K, LIAN Z, SUN B, et al.Role of miR-148a in hepatitis B associated hepatocellular carcinoma[J].PLo S One, 2012, 7 (4) :e35331.
|
|
[41]FENG M, E CY, LI H, et al.Expression of miR-196a in liver cancer cells and its promotion effect on proliferation[J].J Jilin Univ:Med Edit, 2015, 41 (1) :120-124. (in Chinese) 冯默, 鄂长勇, 李航, 等.miR-196a在肝癌细胞中的表达及其促增殖作用[J].吉林大学学报:医学版, 2015, 41 (1) :120-124.
|
|
[42]WU G, YU F, XIAO Z, et al.Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro[J].Br J Cancer, 2011, 105 (1) :146-153.
|
|
[43]HUNG CH, HU TH, LU SN, et al.Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus[J].Int J Cancer, 2016, 138 (3) :714-720.
|
|
[44]BOREL F, KONSTANTINOVA P, JANSEN PL.Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma[J].J Hepatol, 2012, 56 (6) :1371-1383.
|
|
[45]YUNQIAO L, VANKE H, JUN X, et al.MicroRNA-206, downregulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis[J].Hepatogastroenterology, 2014, 61 (133) :1302-1307.
|
|
[46]LIU W, XU C, WAN H, et al.MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma Hep G2 cells[J].Int J Mol Med, 34 (2) :420-428.
|
|
[47]MERQUIOL E, UZI D, MUELLER T, et al.HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response[J].PLo S One, 2011, 6 (9) :e24660.
|
|
[48]XU YX, WANG HQ, ZHAO H, et al, Hippocampal injection of beta amyloid precursor protein antibody induces neuronal degeneration and learning and memory impairment (Eglish) [J].Prog Biochem Biophys, 2011, 38 (10) :908-918. (in Chinese) 许玉霞, 王洪权, 赵红, 等.海马注射β-淀粉样蛋白前体蛋白抗体诱导神经元的退行性变及学习记忆障碍[J].生物化学与生物物理进展, 2011, 38 (10) :908-918.
|
|
[49]XIONG JJ, ZHANG QH, ZHANG YN, et al.Study on the sustained expression of hepatitis C virus NS4B activation in Hep G2 cells by endoplasmic reticulum stress[J].Chongqing Med, 2012, 41 (6) :524-526. (in Chinese) 熊江红, 张庆华, 张艳妮, 等.持续表达的丙型肝炎病毒NS4B激活Hep G2细胞内质网应激反应的研究[J].重庆医学, 2012, 41 (6) :524-526.
|
|
[50]DREUX M, GASTAMINZA P, WIELAND SF, et al.The autophagy machinery is required to initiate hepatitis C virus replication[J].Proc Natl Acad Sci U S A, 2009, 106 (33) :14046-14051.
|
|
[51]LI J, LIU Y, WANG Z, et al.Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment[J].J Virol, 2011, 85 (13) :6319-6333.
|
|
[52]ARZUMANYAN A, FRIEDMAN T, NG IO, et al.Does the hepatitis Bantigen HBx promote the appearance of liver cancer stem cells?[J].Cancer Res, 2011, 71 (10) :3701-3708.
|
|
[53]LIN C, YANG D, JIANG Y, et al.The molecular mechanism of HBx involved in the development and regulation of hepatocellular carcinoma[J].Chin J Biochem Mol Biol, 2013, 29 (8) :704-710. (in Chinese) 林丛, 杨冬, 姜颖, 等.HBx参与肝细胞癌发生发展调控的分子机制[J].中国生物化学与分子生物学报, 2013, 29 (8) :704-710.
|
|
[54]FAN H, ZHANG H, PASCUZZI PE, et al.Hepatitis B virus Xprotein induces Ep CAM expression via active DNA demethylation directed by Rel A in complex with EZH2 and TET2[J].Oncogene, 2016, 35 (6) :715-726.
|
|
[55]JI J, YAMASHITA T, BUDHU A, et al.Identification of microR-NA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells[J].Hepatology, 2009, 50 (2) :472-480.
|
|
[56]LIN LJ, ZHANG JH, WANG Y, et al.Clinicopathological significance of the expression of IMP3 and IGF2 in hepatocellular carcinoma[J].Chin J Clin Exp Pathol, 2013, 29 (4) :361-364. (in Chinese) 林黎娟, 张锦辉, 王研, 等.肝细胞癌组织中IMP3与IGF2表达对预后评估的临床病理学意义[J].临床与实验病理学杂志, 2013, 29 (4) :361-364.
|
|
[57]XU XP, ZHANG ZG, CHE YY, et al.Detection and analysis of serum autoantibodies in patients with HBV infection[J].J Clin Hepatol, 2013, 29 (6) :441-444. (in Chinese) 徐熙鹏, 张钊冠, 车媛媛, 等.HBV感染者血清自身抗体的检测分析[J].临床肝胆病杂志, 2013, 29 (6) :441-444.
|
|
[58]QIN LX, CHEN YL, ZHANG RS, et al.Study on the relationship between hepatitis B virus infection and serum autoantibodies in pregnant women[J].China J Modern Med, 2005, 15 (11) :1712-1714. (in Chinese) 秦立新, 陈远林, 张仁生.孕妇乙型肝炎病毒感染与血清自身抗体的相关性研究[J].中国现代医学杂志, 2005, 15 (11) :1712-1714.
|
|
[59]DONG M, ZHOU HQ, WU JB, et al.Detection and clinical significance of serum antinuclear antibodies in patients with hepatitis B virus infection[J].Lab Med, 2012, 27 (5) :374-375. (in Chinese) 董敏, 周厚清, 吴瑾滨, 等.乙型肝炎病毒感染者血清抗核抗体检测分析及临床意义[J].检验医学, 2012, 27 (5) :374-375.
|
|
[60]HUANG CZ, LI JY, CHEN SP, et al.Expression of IL-2, IL-4, IL-6, IFN-γand IL-17A in hepatocellular carcinoma and their relationship with HBV infection[J].Chin J Immunol, 2015, 31 (4) :527-530. (in Chinese) 黄传钟, 李洁羽, 陈淑萍, 等.IL-2、IL-4、IL-6、IFN-γ、IL-17A在肝癌组织中表达及其与乙肝病毒感染的关系[J].中国免疫学杂志, 2015, 31 (4) :527-530.
|
|
[61]OTANI K, WATANABE T, TANIGAWA T, et al.Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis[J].Biochem Biophys Res Commun, 2009, 382 (2) :252-258.
|
|
[62]QIAO Y, HUANG F, CAO XZ, et al.Study on the correlation between high expression of AID induced by HBV infection and hepatocellular carcinoma[J].Chin J Cancer Prev Treat, 2015, 22 (1) :13-18.乔莹, 黄芬, 蔡鑫泽, 等.HBV感染诱发AID高表达与肝细胞癌变相关性研究[J].中华肿瘤防治杂志, 2015, 22 (1) :13-18.
|
|
[63]GUO TZ, HAN LX, LUO Y, et al.Risk factors of liver cancer in patients with hepatitis B virus infection[J].Int J Virol, 2016, 23 (1) :26-28. (in Chinese) 郭铁志, 韩立新, 罗研, 等.乙型肝炎病毒感染患者肝癌发病的影响因素研究[J].国际病毒学杂志, 2016, 23 (1) :26-28.
|
DownLoad: